Ketamine Completed Phase 2 / 3 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT01558063Ketamine in the Treatment of Depression
NCT02078817Ketamine in Adolescents With Treatment-Resistant Depression
NCT01627782A Study of Ketamine in Patients With Treatment-resistant Depression